Expert Rev Ophthalmol. 2008;3(3):311-323. The new and promising strategies for treating CNV include the use of drugs against VEGF, in particular isoform A, which is the most potent promoter of ...
Please provide your email address to receive an email when new articles are posted on . Overall, 22.5% of patients with myopic normal-tension glaucoma showed progression requiring treatment. Those ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback